Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Cysteine depletion sensitizes prostate cancer cells to agents that enhance DNA damage and to immune checkpoint inhibition.
J Exp Clin Cancer Res. 2023 May 11;42(1):119. doi: 10.1186/s13046-023-02677-2.
J Exp Clin Cancer Res. 2023.
PMID: 37170264
Free PMC article.
Metabolomics-based phenotypic screens for evaluation of drug synergy via direct-infusion mass spectrometry.
Lu X, Hackman GL, Saha A, Rathore AS, Collins M, Friedman C, Yi SS, Matsuda F, DiGiovanni J, Lodi A, Tiziani S.
Lu X, et al. Among authors: friedman c.
iScience. 2022 Apr 7;25(5):104221. doi: 10.1016/j.isci.2022.104221. eCollection 2022 May 20.
iScience. 2022.
PMID: 35494234
Free PMC article.
Item in Clipboard
Novel two-tiered screening approach identifies synergistic combinations of natural compounds for prostate cancer prevention and treatment.
Friedman CA, Saha A, Lavender Hackman G, Lu X, Lodi A, Tiziani S, DiGiovanni J.
Friedman CA, et al.
Mol Carcinog. 2024 Apr;63(4):589-600. doi: 10.1002/mc.23674. Epub 2024 Jan 10.
Mol Carcinog. 2024.
PMID: 38197430
Item in Clipboard
Cite
Cite